exciting updates in essential thrombocythemia: exploring novel agents
Published 1 year ago • 1.1K plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
2:24
update on phase iib study of bomedemstat in essential thrombocythemia
-
3:29
unmet needs and therapeutic strategies in essential thrombocythemia
-
1:57
surpass et: p1101 in essential thrombocythemia
-
3:21
the current standard of care for patients with essential thrombocythemia
-
2:15
advances in the risk stratification and treatment of essential thrombocythemia
-
1:05
hematological predictors of thrombotic risk or disease progression in essential thrombocythemia
-
7:05
hematology oncology rotation | day in the life of a doctor | vlog | bookworm_md
-
8:14
chronic blood cancer at 30 | essential thrombocytosis | mpn
-
26:51
ascp | mls | mlt | essential thrombocythemia | myeloproliferative neoplasms
-
7:58
essential thrombocytosis (et) | myeloproliferative neoplasm (jak2 kinase)
-
0:46
factors associated with progression to myelofibrosis in patients with essential thrombocythemia
-
1:34
are thrombotic risk and progression in et predictable?
-
1:03
most: an observational study of myelofibrosis and essential thrombocythemia
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
8:07
essential thrombocythemia: outcomes, unmet needs, and therapeutic strategies
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
4:48
an insight into the management of cytopenias in mf
-
2:00
the role of fedratinib in 2024 and beyond
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:19
what is essential thrombocythemia (et)?
-
2:41
an overview of the latest advances in hematology